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bjectives This study compared the survival beneﬁt of opening a chronic total occlusion (CTO) of
he left anterior descending (LAD), left circumﬂex (LCX), or right coronary artery (RCA).
ackground Previous analyses demonstrate improved survival following successful percutaneous
oronary intervention (PCI) for CTO.
ethods Eligible patients underwent attempted CTO PCI in a single vessel. Procedural success rates
ere calculated for each vessel. The primary end point was survival at 5 years, compared across tar-
et vessel groups stratiﬁed by procedural success.
esults There were 2,608 patients included. The LAD was the target vessel in 936 (36%), the LCX in
82 (26%), and the RCA in 990 (38%) patients. Angiographic success rates for LAD were 77%, LCX
6%, and RCA 72%. Baseline demographics and comorbidities were well matched, though there
ere signiﬁcantly more males in the LCX compared with LAD or RCA groups (80% vs. 75% and 73%,
espectively, p  0.005). Procedural success compared with failure was associated with improved
-year survival in the LAD (88.9% vs. 80.2%, p  0.001) group, but not in the LCX (86.1% vs. 82.1%,
 0.21) and RCA groups (87.7% vs. 84.9%, p  0.23). In multivariable analysis, CTO PCI success in
he LAD group remained associated with decreased mortality risk (HR: 0.61, 95% CI: 0.42 to 0.89).
onclusions The data suggest that PCI for CTO of the LAD, but not LCX or RCA, is associated with
mproved long-term survival. This information may assist in selecting patients for attempted CTO
CI. (J Am Coll Cardiol Intv 2008;1:295–302) © 2008 by the American College of Cardiology
oundation
rom the *Division of Cardiology and Biostatistics, Saint Luke’s Health System, Mid America Heart Institute, Kansas City,
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296hronic total artery occlusion (CTO) of a coronary artery is
dentified in 13% to 23% of all patients referred for coronary
ngiography and accounts for 7.2% to 15.6% of all percutane-
us coronary intervention (PCI) attempts (1–4). Successful
ecanalization of CTO by PCI is associated with better
ymptom relief, lower risk of subsequent myocardial infarction
MI), and better long-term survival when compared with
See page 303
nsuccessful PCI (5–7). Other recent studies dispute these
ndings, particularly in patients with occluded infarct-
elated arteries (8–11). To date, no study has examined the
otential for differential benefit of CTO recanalization
epending upon the target vessel (e.g., left anterior descend-
ng [LAD], left circumflex [LCX], or right coronary artery
RCA]).
The current study was de-
signed to determine procedural
success, in-hospital outcomes,
and long-term survival in pa-
tients undergoing PCI of a sin-
gle CTO and to compare these
outcomes across each of the 3
major epicardial coronary target
arteries stratified by procedural
success.
Methods
Patient population. Patients
were identified using the PCI
registry at the Mid America
Heart Institute. All patients un-
dergoing attempted PCI of a
single CTO between June 1980
and May 2004 were included in
his analysis. Details of data collection for this registry have
een previously published (5). Dedicated personnel pro-
pectively recorded information, including baseline demo-
raphics, clinical and procedural characteristics, and in-
ospital outcomes. Long-term survival was ascertained
sing hospital records and the U.S. Social Security Death
aster File, which has been shown to be equivalent to the
ational Death Index (12). All patients gave informed
onsent, and the local Institutional Review Board approved
he study.
eﬁnitions. Chronic total occlusion was defined as a lesion
hat displayed Thrombolysis In Myocardial Infarction flow
rade 0 to 1 on initial angiography. Patients with acute MI
ithin 7 days pre-procedure, CTO of a venous or arterial
ypass conduit or left main coronary artery, or undergoing
bbreviations
nd Acronyms
ABG  coronary artery
ypass graft
AD  coronary artery
isease
CS  Canadian
ardiovascular Society
TO  chronic total
cclusion
P  glycoprotein
AD  left anterior
escending
CX  left circumflex
I  myocardial infarction
CI  percutaneous
oronary intervention
CA  right coronary arteryultivessel PCI were excluded. Patients undergoing mul- vivessel PCI were not eligible for inclusion. Each patient
as included in all analyses only once, based on the earliest
rocedure recorded in the database. The target vessel was
ssigned as 1 of the 3 major epicardial vessels if the PCI was
ttempted on that vessel or 1 of its branches (e.g., attempted
CI of an obtuse marginal branch of the LCX was included
n the LCX group).
Angiographic success was defined as successful balloon
ilation of the lesion with or without stent placement and
40% residual stenosis. Procedural success was defined as
ngiographic success with no in-hospital major adverse
ardiac event, defined as death, MI with new Q waves on
lectrocardiogram, or urgent target vessel revascularization
including both repeat PCI and coronary artery bypass graft
CABG] surgery). Non–Q-wave MI was defined as eleva-
ion of creatine kinase-myocardial band fraction to 3
imes the upper limit of normal with recurrent ischemic
ymptoms following PCI. Severe angina was defined as
anadian Cardiovascular Society (CCS) class III to IV, and
enal insufficiency as any serum creatinine 1.5 mg/dl.
urrent smoking was any active smoking within 1 year.
troke was defined as new-onset neurological symptoms
asting 24 h with radiographic and/or neurologic confir-
ation of an event. Hypertension, hypercholesterolemia,
nd diabetes mellitus were recorded in patients on medical
herapy or who self-reported the diagnosis. The number of
iseased vessels was assessed by the physician performing
CI. A vessel with 50% angiographic stenosis was con-
idered diseased.
CI. A PCI was performed using the standard over-the-
ire technique as previously described (13). Over time, the
echnique underwent significant modification, including
arked improvement in devices, case selection, and adjunc-
ive pharmacotherapy. Post-procedural electrocardiograms
ere routinely assessed for new Q waves; however, cardiac
roponin, creatine kinase, and creatine kinase-myocardial
and fraction were not routinely collected.
tatistical analysis. The overall group was divided into
ubgroups based upon the target vessel. In order to display
ny differences in subpopulations, baseline characteristics
ere then compared between vessels using the Student t test
or continuous variables and chi-square or the Fisher exact
est for discrete variables. Data are presented as mean 
tandard deviation for continuous variables and as percent-
ges for discrete variables. The primary end point for this
nalysis was 5-year survival. A priori, the groups of interest
ere defined by procedural success/failure for each vessel
ubpopulation. In order to protect against multiple compar-
sons, a survival analysis with a vessel by procedural success
nteraction was performed first. This interaction term was
tatistically significant, so further survival analyses using
og-rank tests were used to compare the survival curves
etween procedural success/failure groups over time for each
essel. Kaplan-Meier curves were used to depict survival for
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297roups by target vessel and subgroup of procedural success.
urvival analyses using log-rank tests were used to compare
he survival curves between groups over time. Baseline
emographics were compared between those with and
ithout angiographic success to identify significant differ-
nces between groups that may affect the primary outcome.
survival analysis using the Cox proportional hazards
urvival model and adjusted for age, gender, current smok-
ng, prior CABG, number of diseased vessels, angina
everity, and glycoprotein (GP) IIb/IIIa inhibitor use was
erformed to assess the independent contribution of suc-
essful CTO PCI to long-term outcomes. Secondary end
oints included a major adverse cardiac event during the
ospital admission for PCI. To assess the impact of clinical
ariables on procedural success, a multivariable analysis was
erformed including multivessel coronary artery disease
CAD), male gender, smoking, diabetes mellitus, hyperten-
ion, hypercholesterolemia, prior PCI, prior MI, history of
ongestive heart failure, history of chronic renal insuffi-
iency, prior CABG, or GP IIb/IIIa inhibitor use as
ariables of interest and performed separately for each target
TO vessel. All analyses were performed using SAS version
.1 (SAS Institute, Cary, North Carolina) with p values 
.05 considered significant.
esults
aseline demographics. A total of 36,095 PCIs were per-
ormed between June 1980 and May 2004. There were
,979 (8.3%) attempted CTO PCIs during this period. Of
hese, 2,608 (88%) were eligible for this analysis. Among all
atients, 20.6% had CCS class I angina and 58.9% had CCS
lass III to IV. By target vessel, CTO PCI was performed
Table 1. Demographics
Variable LAD (n  936)
Age, yrs, mean (SD) 62 (12)
Male gender, n (%) 699 (75)
Current smoking, n (%) 571 (65)
Diabetes mellitus, n (%) 211 (23)
Hypertension, n (%) 485 (52)
Hyperlipidemia, n (%) 570 (63)
Prior PCI, n (%) 367 (39)
Prior CABG, n (%) 155 (17)
Prior MI, n (%) 474 (51)
Prior CHF, n (%) 55 (5.9)
Ejection fraction, % (SD) 37 (24)
Renal insufﬁciency, n (%) 32 (3)
Severe angina, n (%) 556 (60)
CABG coronary artery bypass graft; CHF congestive heart failure; LAD left anterior descending
coronary artery; SD standard deviation.n the LAD in 936 (36%), LCX in 682 (26%), and RCA in 790 (38%) patients. Baseline patient characteristics by target
essel are presented in Table 1. Male gender and prior
ABG were significantly more common in LCX patients,
ut current smoking was more common in the RCA group.
ean left ventricular ejection fraction was significantly
reater in patients with a RCA target vessel compared with
AD or LCX (0.37  0.24 vs. 0.37  0.25 and 0.40 
.24, respectively, p  0.006). There were no differences in
ngina severity across groups.
rocedural characteristics. Overall, 468 patients (18%) re-
eived stents, most commonly in the RCA group (Table 2).
se of other adjunctive therapies, including directional or
otational atherectomy, laser, and GP IIb/IIIa inhibitors,
as relatively uncommon and did not differ by target vessel.
Angiographic success rates varied across groups (Table 2).
n the entire study group, patient characteristics among
hose with angiographic success were similar to the group
ith angiographic failure. Among the LAD subgroup,
owever, those with successful CTO PCI were younger, less
ften male, had lower prevalence of smoking and prior
ABG, and had a higher mean ejection fraction compared
ith those with unsuccessful PCI (Table 3). Among LCX
atients, history of prior CABG was more common in the
roup with procedural failure than success (29% vs. 21%, p
0.03). There were no significant demographic differences
etween the RCA patients with success versus failure.
n-hospital complications. In-hospital complications, in-
luding death, target vessel revascularization, and major
dverse cardiac event rates, were more common in the LAD
TO group (Table 4). In-hospital CABG was most com-
on in the RCA CTO group. Procedural success rates for
he LAD, LCX, and RCA groups were 75%, 75%, and
rget Vessel
p Value(n  682) RCA (n  990)
61 (12) 62 (12) 0.30
541 (80) 717 (73) 0.005
445 (69) 683 (71) 0.007
155 (23) 207 (21) 0.59
372 (55) 550 (56) 0.24
453 (67) 656 (67) 0.05
275 (40) 373 (38) 0.54
155 (23) 160 (16)  0.001
351 (52) 458 (46) 0.06
25 (3.7) 45 (4.5) 0.11
37 (25) 40 (24) 0.006
24 (4) 25 (3) 0.41
403 (59) 576 (58) 0.84
left circumflex;MImyocardial infarction; PCIpercutaneous coronary intervention; RCA rightTa
LCX
; LCX1%, respectively (p  0.06) (Table 2). Overall, in-hospital
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298ortality among patients in the LAD group was signifi-
antly greater than the RCA or LCX groups (Table 4).
ecause all deaths are considered procedural failures, the
n-hospital mortality rate in patients with unsuccessful
TO PCI of the LAD (n  234) was 7.7% (n  18).
redictors of procedural success. In the LAD group, smok-
ng (OR: 0.60, 95% CI: 0.42 to 0.85), increasing age per 10
ears (OR: 0.86, 95% CI: 0.75 to 0.99), and multivessel
AD (OR: 0.43, 95% CI: 0.29 to 0.61) were associated
ith a lower likelihood of procedural success, but GP
Ib/IIIa use (OR: 2.23, 95% CI: 1.17 to 5.05) was associated
ith increased success. Among those in the LCX group,
rior CABG was associated with decreased procedural
uccess (OR: 0.61, 95% CI: 0.41 to 0.92), but GP IIb/IIIa
se was associated with increased success (OR: 2.57, 95%
I: 1.07 to 6.17). Glycoprotein IIb/IIIa use was associated
ith increased procedural success in the RCA group (OR:
.56, 95% CI: 1.36 to 4.80).
Table 2. Procedural Characteristics
Procedure Information LAD (n  936)
Number of diseased vessels, n (%)
1 335 (36)
2 301 (32)
3 300 (32)
GP IIb/IIIa inhibitor, n (%) 96 (10)
Stent deployed, n (%) 149 (16)
Atherectomy 7 (0.7)
Rotablator 25 (2.7)
Laser 7 (0.7)
Residual dissection, n (%) 150 (18)
Angiographic success, n (%) 719 (77)
Procedural success, n (%) 702 (75)
GP glycoprotein; other abbreviations as in Table 1.
Table 3. LAD Procedural Success Demographics
Demographics
LAD Success
(n  702)
Age, yrs (SD) 62 (12)
Male gender, n (%) 512 (73)
Smoking current, n (%) 409 (62)
Diabetes, n (%) 153 (22)
History of hypertension, n (%) 364 (52)
History of hyperlipidemia, n (%) 424 (62)
Prior PCI, n (%) 270 (39)
Prior CABG, n (%) 103 (15)
Prior MI, n (%) 357 (51)
History of CHF, n (%) 40 (5.7)
Ejection fraction, %, mean (SD) 38 (24)
Severe angina, n (%) 424 (61)Abbreviations as in Table 1.-year survival. Average follow-up was 10.5 years for LAD
atients, 9.8 years for LCX patients, and 9.9 years for RCA
atients. Procedural success compared with failure was
ssociated with improved 5-year survival in the LAD
88.9% vs. 80.2%, p  0.001) groups, but not in the LCX
86.1% vs. 82.1%, p  0.21) and RCA groups (87.7% vs.
4.9%, p 0.23) (Figs. 1A to 1C). There was no significant
ifference in 5-year survival among those with angiographic
ailure stratified by vessel attempted (p  0.49). Overall,
re-procedural severe angina was associated with decreased
-year survival (CCS class III-IV 84.6% vs. CCS class I to
I 87.3%, p  0.046).
Multivariable adjusted predictors of long-term survival
re presented in Figure 2. After adjusting for demographic
nd procedural differences between the success and failure
roups, successful CTO PCI remained associated with
mproved long-term survival in the LAD group (HR: 0.61,
5% CI: 0.42 to 0.89). The difference was not significant in
Target Vessel
p ValueLCX (n  682) RCA (n  990)
 0.001
117 (17) 247 (25)
234 (34) 386 (39)
331 (49) 357 (36)
72 (11) 103 (10) 0.98
113 (17) 206 (21) 0.01
7 (1.0) 5 (0.5) 0.47
13 (1.9) 29 (2.9) 0.42
10 (1.5) 17 (1.7) 0.16
126 (21) 173 (20) 0.32
515 (76) 711 (72) 0.03
509 (75) 699 (71) 0.06
LAD Failure
(n  234) p Value
64 (12) 0.02
187 (80) 0.03
162 (73) 0.003
58 (25) 0.34
121 (52) 0.97
146 (65) 0.45
97 (42) 0.42
52 (22) 0.007
117 (50) 0.82
15 (6) 0.69
35 (24) 0.09
132 (57) 0.29
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299he LCX (HR: 0.84, 95% CI: 0.53 to 1.32) and RCA
roups (HR: 0.95, 95% CI: 0.63 to 1.44). Severe angina did
ot significantly affect survival in adjusted analyses. Age (per
0-year increase) predicted mortality in all 3 groups, but
ultivessel CAD and GP IIb/IIIa inhibitor use predicted
ortality only in the LAD group. Current smoking pre-
icted mortality in the RCA group (Fig. 2).
iscussion
ur findings suggest a survival benefit of successful CTO
CI of the LAD (as compared to CTO PCI failure) that is
ot evident in the LCX or RCA subpopulations. Procedural
uccess was associated with an improvement in survival only
mong those with LAD CTO. There was no similar
mprovement in survival following successful CTO PCI of
he LCX or RCA. To our knowledge, our study is the first
o identify a differential benefit by CTO vessel treated in a
arge group.
Our hypothesis that the survival advantage conferred by
uccessful CTO PCI depends on the culprit vessel was
ased on previous studies suggesting that LAD occlusion
ither in acute MI (14,15) or chronic stable coronary
yndromes (16) is prognostically significant, whereas lesions
n the LCX and RCA are less so. Finding this association
etween procedural success and improved survival in the
AD but not LCX and RCA groups supports this hypoth-
sis. We also identified increased risk in the LAD group,
ith a high cost (i.e., in-hospital mortality) of CTO PCI
ailure. Although overall in-hospital mortality was 1.9% in
he entire group, it was 7.7% among patients with failed
ttempt at CTO PCI of the LAD. This observation also
aises questions about how to optimally select patients for
TO PCI in the future.
Prior studies have given discrepant results when evaluat-
ng long-term survival following CTO PCI. Recently,
nvestigators at the Mayo Clinic reported technical failure of
TO PCI was not associated with increased 10-year mor-
Table 4. In-Hospital Outcomes
LAD (n  936)
Death, n (%) 18 (1.9)
MI, n (%) 26 (2.8)
Q-wave, n (%) 2 (0.2)
Target vessel revascularization, n (%) 13 (1.4)
Bypass surgery, n (%) 25 (2.7)
Stroke, n (%) 0 (0.0)
Major adverse event, n (%) 37 (4.0)
Vascular complication, n (%) 15 (1.6)
Surgical repair, n (%) 6 (0.6)
Bleeding requiring transfusion, n (%) 10 (1.1)
Abbreviations as in Table 1.ality (10). Although these findings differ from others (5,6), shey highlight the need for further study to optimize
edical decision making.
In the current study, the prevalence of severe angina did
ot differ between patients with procedural success or failure
r by target vessel. Overall, 5-year survival following at-
empted CTO PCI was poorer among patients with severe
re-procedural angina. However, in multivariable analysis,
ngina class had no significant association with long-term
urvival. This differs from prior reports, in which increased
ortality correlated with severity of angina in stable outpa-
ients (17), and improvements in left ventricular function
ollowing CTO PCI correlated with angina severity (18).
It is possible that some of these clinical variables are
elated directly to procedural success, thus influencing sur-
ival. Although our primary interest was not to define
linical variables associated with procedural success of at-
empted CTO PCI, our data do provide interesting obser-
ations. First, GP IIb/IIIa antagonist use was associated
ith procedural success in all 3 study groups. In the LAD
roup, smoking, increased age (per 10 years), and single-
essel CAD were associated with decreased procedural
uccess, but in the LCX group, prior CABG was associated
ith decreased procedural success. Multivessel CAD has
reviously been associated with technically unsuccessful
TO recanalization (7). Other factors that may impact
uccess, such as lesion length and morphology, calcification,
nd collateralization, were not evaluated in this study.
It is the task of the interventional cardiologist to incor-
orate this sometimes discordant data into the decision-
aking process when faced with a patient presenting with a
TO. The presence of a CTO on diagnostic angiography is
nown to impact selection of treatment strategy, decreasing
he likelihood of PCI (19). There are several potential
easons why PCI may be deferred, 1 of which is the presence
f collateral vessels. However, the “protection” offered to
t-risk myocardium is limited, with a normal coronary flow
eserve in only 7% of collateralized vessels, and coronary
LCX (n  682) RCA (n  990) p Value
3 (0.4) 5 (0.5) 0.002
25 (3.7) 24 (2.4) 0.32
1 (0.1) 5 (0.5) 0.35
2 (0.3) 3 (0.3) 0.006
10 (1.5) 35 (3.5) 0.04
1 (0.1) 1 (0.1) 0.54
11 (1.6) 19 (1.9) 0.003
10 (1.5) 14 (1.4) 0.94
2 (0.3) 4 (0.4) 0.56
6 (0.9) 10 (1.0) 0.93teal syndrome in one-third of interrogated vessels (20).
a
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descending (LAD), (B) left circumﬂex (LCX), and (C) right coronary artery (RCA).
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300Another potential reason for deferring CTO PCI is the
bsence of severe angina. In multivariable analysis, angina
everity had no impact on outcomes in our data. However,
pproximately 60% of patients included in this study had
evere (CCS class III-IV) angina, and all patients included
ere referred for angiography for clinical indications, in-
luding angina, MI, and high-risk noninvasive testing. A
imited number of patients in this study (20.6%) had CCS
lass I angina. Due to these limitations, the current findings
ay not be generalizable to asymptomatic patients or those
ith mild angina.
Prior to undergoing attempted CTO PCI, patients
Figure 2. Multivariable Predictors of Survival Following CTO PCI
Multivariable adjusted predictors of long-term survival in patients undergo-
ing percutaneous coronary intervention of chronic total occlusions in left
anterior descending, left circumﬂex, and right coronary artery. CABG  cor-
onary artery bypass graft; CAD  coronary artery disease; other abbrevia-
tions as in Figure 1.Figure 1. Survival Following Successful Versus Failed CTO PCI
Kaplan-Meier survival curves by success versus failure of percutaneous coro-
nary intervention (PCI) of chronic total occlusions (CTO) in (A) left anteriorhould be assured that the potential benefits justify the risks
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301f the procedure. For instance, radiation exposure is signif-
cantly higher for CTO PCI than for non–CTO PCI (21).
lthough some studies suggest that overall survival is
mproved by successful CTO PCI, the benefit may be
imited to certain subgroups. For instance, our group has
reviously shown no improvement in survival among dia-
etic patients with successful compared with unsuccessful
TO PCI (22). The current study extends this observation
o the target PCI vessel. Those with CTO of the LAD had
39% relative risk reduction in death at 5 years (p  0.01).
he relative risk reduction was 14% in the LCX and 18% in
he RCA (pNS for both) groups. Clarifying the potential
urvival benefit will hopefully improve communication be-
ween physicians and patients and add to the assessment of
he potential benefits and risks of CTO PCI by the
hysician and the patient, increasing the dataset upon which
herapeutic decisions may be based.
Improving survival is not the only potential benefit of
TO PCI. There are also improvements in clinical out-
omes such as reduced incidence of MI, reduced need for
ABG, and significant reductions in angina burden after
TO PCI (7,23). Improvements in regional and global wall
otion are evident on myocardial perfusion scintigraphy,
chocardiography, and left ventriculography following PCI
f CTO (18,24,25). Positive effects on left ventricular
emodeling have been reported in patients undergoing
ardiac magnetic resonance imaging up to 3 years after
TO PCI (26). These potential benefits may justify at-
empted CTO PCI despite a lack of significant improve-
ents in survival in some patient subsets.
Optimal timing of CTO PCI is becoming evident in
ecent publications. In the OAT (Open Artery Trial) (11),
CI of infarct-related arteries 3 to 28 days after MI did not
educe death, recurrent MI, or congestive heart failure over
years. The TOSCA (Total Occlusion Study of Canada)-2
ubstudy (9) reported no improvement in left ventricular
unction at 1 year. Given these findings, it may be best to
llow recovery from acute MI if the presentation to the
nterventional suite falls within this time frame.
Although the survival benefit associated with successful
TO PCI may be limited to the LAD, there are multiple
ther benefits of coronary revascularization that need to be
onsidered when recommending therapy. By incorporating
he current data with prior reports into a discussion with the
atient, it is our hope that health care providers will be able
o provide meaningful informed consent. This will encour-
ge the formulation of a treatment plan consistent with the
ishes of patients after consideration of all relevant treat-
ent options. It takes a thorough review of the case history,
omorbidities, anatomy, and noninvasive testing to enter
nto a discussion with the patient regarding the procedural
isks and benefits. In appropriate situations, CTO PCI can
eliver benefits to the patient, including decreased angina
urden, improved ejection fraction, and possibly improved cong-term survival. It is left to the treating physician to have
thorough dialogue with the patient to arrive at a treatment
lan, including CTO PCI when appropriate.
tudy limitations. This was an observational study. Hypoth-
sis generation and analysis were retrospectively conducted
n prospectively collected data, creating potential post hoc
nalysis bias. This is an assessment of the benefits of
uccessful CTO PCI as compared with failed CTO PCI. As
uch, there is no medical therapy group for comparison.
hese data should not be interpreted as a comparison of
CI and medical therapy in the treatment of CTO. Tech-
ology has evolved substantially over the years during which
he data were collected. For example, only 18% of the
atients in this analysis underwent stent placement, and
rug-eluting stents were not available during the study
eriod (only 3 patients in this analysis received drug-eluting
tents). During this time, the database was modified to
ollect more covariables than originally included, thus po-
entially excluding important predictors of outcomes not
ecorded in the early experience. Additionally, there are a
imited number of anatomic- and lesion-specific variables
ecorded in the database, including collateralization and
pecific lesion location, thus limiting our ability to analyze
he impact of detailed vessel characteristics on procedural
uccess or long-term survival and potentially biasing our
esults if there were a disproportionate number of side-
ranch or distal vessel PCIs in the LCX or RCA groups.
he duration of CTO was not known for the entire group,
lthough patients with evidence of MI within the 7 days
efore the index procedure were excluded from this analysis.
ardiac troponin and creatine phosphokinase data were not
outinely collected following PCI during the study period,
ut only when there was clinical evidence of MI. Electro-
ardiograms were routinely screened for new Q waves.
Although thorough review of databases from large ter-
iary care centers provides some insight into the effect of
TO PCI on long-term outcomes, a randomized clinical
rial would be necessary to adequately control for the
ifferences between patients with procedural success or
rocedural failure. Retrospective analyses should be inter-
reted for with some caution, for while they do provide
seful data, they may be subject to unforeseen, unidentifi-
ble confounders that can only be adequately addressed in
he setting of a randomized trial.
onclusions
ur data suggest that successful CTO PCI is associated
ith an improvement in long-term survival as compared to
TO PCI failure in the subpopulation of patients with
AD CTO. Therefore, attempted PCI of LAD CTO may
e justified to improve survival. This improvement is not
vident among those with LCX or RCA occlusion, and no
omparison to medical therapy is possible with these data.
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302TO PCI should be attempted only after a detailed
iscussion of the potential risks and benefits of the proce-
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